• SENSEX
    NIFTY 50
Market

Top brokerage calls for July 15: Citi upgrades Infosys, Credit Suisse remains bearish; CLSA positive on IndusInd Bank

Updated : 2019-07-15 08:15:28

Indian benchmark indices are likely to open little changed on Monday as investors await first-quarter results. Asian shares traded lower after China reported a GDP growth of 6.2 percent in the second quarter from a year earlier, the weakest pace in at least 27 years. Among brokerages, Citi upgraded Infosys to 'buy', while, Credit Suisse had an 'underperform' rating on the stock. CLSA remained bullish on IndusInd Bank but bearish on Pidilite. Here are the top brokerage calls for Monday:

<strong>Citi on Infosys:</strong> The brokerage upgraded the stock to 'buy' and raised the target price to Rs 820 per share. While EBIT is in-line, deal wins and revenue guidance being raised are positives, it added.
Citi on Infosys: The brokerage upgraded the stock to 'buy' and raised the target price to Rs 820 per share. While EBIT is in-line, deal wins and revenue guidance being raised are positives, it added.
<strong>HSBC on Infosys:</strong> The brokerage maintained a 'hold' rating for the stock but raised its target price to Rs 780 per share. It added that near-term margin is at risk as large deals ramp up.
HSBC on Infosys: The brokerage maintained a 'hold' rating for the stock but raised its target price to Rs 780 per share. It added that near-term margin is at risk as large deals ramp up.
<strong>Credit Suisse on Infosys:</strong> The brokerage maintained an 'underperform' call on the stock with a target price of Rs 670 per share. The brokerage said Infosys' organic growth at 2.2 percent (QoQ) below an estimate of 2.4 percent.
Credit Suisse on Infosys: The brokerage maintained an 'underperform' call on the stock with a target price of Rs 670 per share. The brokerage said Infosys' organic growth at 2.2 percent (QoQ) below an estimate of 2.4 percent.
<strong>CLSA on IndusInd Bank</strong>: The brokerage remained bullish on the stock and is encouraged by management's cautious approach on lending.
CLSA on IndusInd Bank: The brokerage remained bullish on the stock and is encouraged by management's cautious approach on lending.
<strong>Morgan Stanley on Avenue Supermarts</strong>: The brokerage maintained an 'underweight' call on the stock and said the changing retail landscape will have implications on the company's revenue growth and margin.
Morgan Stanley on Avenue Supermarts: The brokerage maintained an 'underweight' call on the stock and said the changing retail landscape will have implications on the company's revenue growth and margin.
<strong>Morgan Stanley on Sun Pharma:</strong> The brokerage upgraded the stock by two-notch to 'overweight' and raised its target to Rs 505 per share. It expects a revival in earnings from FY21.
Morgan Stanley on Sun Pharma: The brokerage upgraded the stock by two-notch to 'overweight' and raised its target to Rs 505 per share. It expects a revival in earnings from FY21.
<strong>CLSA on Pidilite:</strong> The brokerage maintained a 'sell' call on the stock with a target at Rs 1,060 per share. It said the company's weak arts and materials growth over the last five years is a concern.
CLSA on Pidilite: The brokerage maintained a 'sell' call on the stock with a target at Rs 1,060 per share. It said the company's weak arts and materials growth over the last five years is a concern.
<strong>CLSA on Lupin</strong>: CLSA maintained a 'sell' call on Lupin; said most of the company's initiatives are expected to fructify only in FY21.
CLSA on Lupin: CLSA maintained a 'sell' call on Lupin; said most of the company's initiatives are expected to fructify only in FY21.
Live TV

Ask Our Experts CNBC TV18